Brusa I, Sondo E, Falchi F, Pedemonte N, Roberti M, Cavalli A
J Med Chem. 2022; 65(7):5212-5243.
PMID: 35377645
PMC: 9014417.
DOI: 10.1021/acs.jmedchem.1c01897.
Strejczek A, Woszczyk D, Urbaniak H, Rozanska M, Robak M, Matuszewska Z
Int J Mol Sci. 2021; 22(9).
PMID: 34066495
PMC: 8124462.
DOI: 10.3390/ijms22094925.
Mrakovcic M, Kleinheinz J, Frohlich L
Int J Mol Sci. 2019; 20(10).
PMID: 31096697
PMC: 6567317.
DOI: 10.3390/ijms20102415.
Mrakovcic M, Kleinheinz J, Frohlich L
Int J Mol Sci. 2018; 18(9).
PMID: 30563957
PMC: 5618532.
DOI: 10.3390/ijms18091883.
Mrakovcic M, Bohner L, Hanisch M, Frohlich L
Int J Mol Sci. 2018; 19(12).
PMID: 30544838
PMC: 6321134.
DOI: 10.3390/ijms19123952.
Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.
Hui K, Tam K, Chiang A
Viruses. 2017; 9(11).
PMID: 29160853
PMC: 5707559.
DOI: 10.3390/v9110352.
Molecular mechanism leading to SAHA-induced autophagy in tumor cells: evidence for a p53-dependent pathway.
Frohlich L, Mrakovcic M, Smole C, Zatloukal K
Cancer Cell Int. 2016; 16(1):68.
PMID: 27601937
PMC: 5011867.
DOI: 10.1186/s12935-016-0343-0.
Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 Prostate Cancer Cells.
Rosati R, Chen B, Patki M, McFall T, Ou S, Heath E
Mol Pharmacol. 2016; 90(3):225-37.
PMID: 27382012
PMC: 4998664.
DOI: 10.1124/mol.116.103416.
Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem.
Luqmani Y, Alam-Eldin N
Med Princ Pract. 2016; 25 Suppl 2:28-40.
PMID: 26849149
PMC: 5588530.
DOI: 10.1159/000444451.
Histone deacetylase inhibition impairs normal intestinal cell proliferation and promotes specific gene expression.
Roostaee A, Guezguez A, Beausejour M, Simoneau A, Vachon P, Levy E
J Cell Biochem. 2015; 116(11):2695-708.
PMID: 26129821
PMC: 5014201.
DOI: 10.1002/jcb.25274.
Mechanisms of aromatase inhibitor resistance.
Ma C, Reinert T, Chmielewska I, Ellis M
Nat Rev Cancer. 2015; 15(5):261-75.
PMID: 25907219
DOI: 10.1038/nrc3920.
Effects of Trichostatin A on In vitro Development of Porcine Embryos Derived from Somatic Cell Nuclear Transfer.
Jeong Y, Park C, Kim H, Jeong Y, Lee J, Park S
Asian-Australas J Anim Sci. 2014; 26(12):1680-8.
PMID: 25049758
PMC: 4092892.
DOI: 10.5713/ajas.2013.13029.
Epigenetic mechanisms in cerebral ischemia.
Schweizer S, Meisel A, Marschenz S
J Cereb Blood Flow Metab. 2013; 33(9):1335-46.
PMID: 23756691
PMC: 3764391.
DOI: 10.1038/jcbfm.2013.93.
Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.
Garcia-Becerra R, Santos N, Diaz L, Camacho J
Int J Mol Sci. 2013; 14(1):108-45.
PMID: 23344024
PMC: 3565254.
DOI: 10.3390/ijms14010108.
PLK1 inhibitors synergistically potentiate HDAC inhibitor lethality in imatinib mesylate-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivo.
Dasmahapatra G, Patel H, Nguyen T, Attkisson E, Grant S
Clin Cancer Res. 2012; 19(2):404-14.
PMID: 23204129
PMC: 3548959.
DOI: 10.1158/1078-0432.CCR-12-2799.
A chemocentric approach to the identification of cancer targets.
Flachner B, Lorincz Z, Carotti A, Nicolotti O, Kuchipudi P, Remez N
PLoS One. 2012; 7(4):e35582.
PMID: 22558171
PMC: 3338416.
DOI: 10.1371/journal.pone.0035582.
Regulation of immune responses by histone deacetylase inhibitors.
Licciardi P, Karagiannis T
ISRN Hematol. 2012; 2012:690901.
PMID: 22461998
PMC: 3313568.
DOI: 10.5402/2012/690901.
Protein arginine deiminase 4: a target for an epigenetic cancer therapy.
Slack J, Causey C, Thompson P
Cell Mol Life Sci. 2010; 68(4):709-20.
PMID: 20706768
PMC: 3815436.
DOI: 10.1007/s00018-010-0480-x.
Enhanced radiosensitivity of EC109 cells by inhibition of HDAC1 expression.
Zhang B, Wang Y, Pang X
Med Oncol. 2010; 29(1):340-8.
PMID: 20464640
DOI: 10.1007/s12032-010-9559-3.
A phase I study of vorinostat in combination with idarubicin in relapsed or refractory leukaemia.
Kadia T, Yang H, Ferrajoli A, Maddipotti S, Schroeder C, Madden T
Br J Haematol. 2010; 150(1):72-82.
PMID: 20456355
PMC: 4124904.
DOI: 10.1111/j.1365-2141.2010.08211.x.